NO20081198L - Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptor - Google Patents
Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptorInfo
- Publication number
- NO20081198L NO20081198L NO20081198A NO20081198A NO20081198L NO 20081198 L NO20081198 L NO 20081198L NO 20081198 A NO20081198 A NO 20081198A NO 20081198 A NO20081198 A NO 20081198A NO 20081198 L NO20081198 L NO 20081198L
- Authority
- NO
- Norway
- Prior art keywords
- patient
- predicting
- monitoring
- procedure
- response
- Prior art date
Links
- 102000001301 EGF receptor Human genes 0.000 title abstract 2
- 108060006698 EGF receptor Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000012544 monitoring process Methods 0.000 title 1
- 230000035772 mutation Effects 0.000 abstract 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2005003823 | 2005-10-05 | ||
| PCT/GB2005/004036 WO2007039705A1 (fr) | 2005-10-05 | 2005-10-20 | Méthode pour prédire ou surveiller la réponse d'un patient à un médicament de récepteur erbb |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081198L true NO20081198L (no) | 2008-06-30 |
Family
ID=36114238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081198A NO20081198L (no) | 2005-10-05 | 2008-03-06 | Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080286785A1 (fr) |
| EP (1) | EP1931798A1 (fr) |
| JP (1) | JP2009511008A (fr) |
| KR (1) | KR20080028857A (fr) |
| CN (1) | CN101351563A (fr) |
| AU (1) | AU2005337051A1 (fr) |
| BR (1) | BRPI0520530A2 (fr) |
| CA (1) | CA2624613A1 (fr) |
| IL (1) | IL189705A0 (fr) |
| NO (1) | NO20081198L (fr) |
| NZ (1) | NZ566387A (fr) |
| TW (1) | TW200714716A (fr) |
| WO (1) | WO2007039705A1 (fr) |
| ZA (1) | ZA200802854B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2364495T3 (es) | 2005-02-03 | 2011-09-05 | The General Hospital Corporation | Método para tratar cáncer resistente a gefitinib. |
| RU2451524C2 (ru) | 2005-11-04 | 2012-05-27 | Вайет | Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272 |
| NZ579644A (en) | 2007-02-16 | 2012-05-25 | Merrimack Pharmaceuticals Inc | Antibodies against erbb3 and uses thereof |
| US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| EP2915532B1 (fr) | 2008-06-17 | 2016-10-19 | Wyeth LLC | Combinaisons antinéoplasiques contenant du HKI-272 et de la vinorelbine |
| EP4424375A3 (fr) | 2008-08-04 | 2024-11-20 | Wyeth LLC | Combinaisons antinéoplasiques de nératinib et de capécitabine |
| US8623592B2 (en) | 2008-08-15 | 2014-01-07 | Merrimack Pharmaceuticals, Inc. | Methods and systems for predicting response of cells to a therapeutic agent |
| ES2941894T3 (es) | 2009-04-06 | 2023-05-26 | Wyeth Llc | Régimen de tratamiento que utiliza neratinib contra el cáncer de mama |
| SG176571A1 (en) * | 2009-05-19 | 2012-01-30 | Vivia Biotech Sl | Methods for providing personalized medicine tests ex vivo for hematological neoplasms |
| JP2013510564A (ja) | 2009-11-13 | 2013-03-28 | パンガエア ビオテック、ソシエダッド、リミターダ | 肺癌におけるチロシンキナーゼ阻害剤に対する応答を予測するための分子バイオマーカー |
| TWI630916B (zh) * | 2009-11-13 | 2018-08-01 | 第一三共歐洲公司 | 供治療或預防人表皮生長因子受體－３（ｈｅｒ－３）相關疾病之藥料和方法 |
| SG183532A1 (en) | 2010-03-11 | 2012-09-27 | Merrimack Pharmaceuticals Inc | Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| EP3219814B1 (fr) * | 2010-10-29 | 2023-02-15 | ARKRAY, Inc. | Sonde de détection de polymorphisme dans le gène egfr, amorce d'amplification et utilisation associée |
| WO2012065071A2 (fr) * | 2010-11-12 | 2012-05-18 | The Broad Institute Of Mit And Harvard | Procédés de prédiction d'une réponse à une thérapie par un anticorps anti-egfr |
| EP2468883A1 (fr) | 2010-12-22 | 2012-06-27 | Pangaea Biotech S.L. | Biomarqueurs moléculaires pour la prédiction de la réponse aux inhibiteurs de la tyrosine kinase dans le cancer du poumon |
| EP2492688A1 (fr) | 2011-02-23 | 2012-08-29 | Pangaea Biotech, S.A. | Biomarqueurs moléculaires pour la prédiction de la réponse à un traitement antitumoral dans le cancer du poumon |
| CN103255201B (zh) * | 2012-02-16 | 2017-07-14 | 江苏宏微特斯医药科技有限公司 | 一种基于Blocker引物和ARMS引物检测基因突变的方法和试剂盒 |
| WO2013190089A1 (fr) | 2012-06-21 | 2013-12-27 | Pangaea Biotech, S.L. | Biomarqueurs moléculaires permettant de prédire l'issue dans le cancer du poumon |
| CN105229173A (zh) * | 2013-03-08 | 2016-01-06 | 豪夫迈·罗氏有限公司 | Egfr突变血液测试 |
| WO2015100459A2 (fr) | 2013-12-27 | 2015-07-02 | Merrimack Pharmaceuticals, Inc. | Profils de biomarqueur pour prédire les résultats d'une thérapie cancéreuse utilisant des inhibiteurs d'erbb3 et/ou des chimiothérapies |
| CA2961437C (fr) * | 2014-10-09 | 2019-01-15 | F. Hoffmann-La Roche Ag | Nouvelles mutations complexes dans le domaine kinase du recepteur de facteur de croissance epidermique |
| GB201507202D0 (en) * | 2015-04-28 | 2015-06-10 | Stfc Science & Technology | Receptor tyosine kinase biomarkers |
| US10184006B2 (en) | 2015-06-04 | 2019-01-22 | Merrimack Pharmaceuticals, Inc. | Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors |
| CN115844877B (zh) * | 2017-01-10 | 2024-07-23 | 浙江嘉驰医药开发有限公司 | 拉索昔芬调节膜结合雌激素信号的应用及治疗癌症的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9403953D0 (sv) * | 1994-07-15 | 1994-11-16 | Pharmacia Biotech Ab | Sequence-based diagnosis |
| US6759217B2 (en) * | 1996-03-26 | 2004-07-06 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| GB9812768D0 (en) * | 1998-06-13 | 1998-08-12 | Zeneca Ltd | Methods |
| JP2007527241A (ja) * | 2004-03-01 | 2007-09-27 | ユニバーシティ オブ シカゴ | 上皮細胞成長因子受容体遺伝子プロモーターにおける多型 |
| CN104774931B (zh) * | 2004-03-31 | 2017-11-10 | 综合医院公司 | 测定癌症对表皮生长因子受体靶向性治疗反应性的方法 |
| WO2005118876A2 (fr) * | 2004-06-04 | 2005-12-15 | Genentech, Inc. | Mutations de egfr |
| GB2424886A (en) * | 2005-04-04 | 2006-10-11 | Dxs Ltd | Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations |
| US20060223178A1 (en) * | 2005-04-05 | 2006-10-05 | Tom Barber | Devices and methods for magnetic enrichment of cells and other particles |
-
2005
- 2005-10-20 CN CNA2005800517835A patent/CN101351563A/zh active Pending
- 2005-10-20 JP JP2008534061A patent/JP2009511008A/ja active Pending
- 2005-10-20 BR BRPI0520530-1A patent/BRPI0520530A2/pt not_active IP Right Cessation
- 2005-10-20 NZ NZ566387A patent/NZ566387A/en not_active IP Right Cessation
- 2005-10-20 KR KR1020087005875A patent/KR20080028857A/ko not_active Ceased
- 2005-10-20 EP EP05803602A patent/EP1931798A1/fr not_active Withdrawn
- 2005-10-20 WO PCT/GB2005/004036 patent/WO2007039705A1/fr not_active Ceased
- 2005-10-20 ZA ZA200802854A patent/ZA200802854B/xx unknown
- 2005-10-20 CA CA002624613A patent/CA2624613A1/fr not_active Abandoned
- 2005-10-20 AU AU2005337051A patent/AU2005337051A1/en not_active Abandoned
- 2005-12-13 TW TW094143956A patent/TW200714716A/zh unknown
-
2008
- 2008-02-24 IL IL189705A patent/IL189705A0/en unknown
- 2008-03-06 NO NO20081198A patent/NO20081198L/no not_active Application Discontinuation
- 2008-04-07 US US12/080,959 patent/US20080286785A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009511008A (ja) | 2009-03-19 |
| WO2007039705A1 (fr) | 2007-04-12 |
| US20080286785A1 (en) | 2008-11-20 |
| EP1931798A1 (fr) | 2008-06-18 |
| NZ566387A (en) | 2010-05-28 |
| BRPI0520530A2 (pt) | 2009-09-29 |
| IL189705A0 (en) | 2008-06-05 |
| KR20080028857A (ko) | 2008-04-01 |
| ZA200802854B (en) | 2009-06-24 |
| AU2005337051A1 (en) | 2007-04-12 |
| TW200714716A (en) | 2007-04-16 |
| CN101351563A (zh) | 2009-01-21 |
| CA2624613A1 (fr) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081198L (no) | Fremgangsmate for a predikere eller monitorere en pasients respons til et medikament rettet mot en ErbB-reseptor | |
| DK1991697T3 (da) | DNA-konformation (LOOP-strukturer) ved normal og anormal genekspression | |
| WO2007134166A3 (fr) | Dépistage en temps réel du virus de l'influenza | |
| WO2007001342A3 (fr) | Recueil de condensat d'haleine expiree (ebc) et systeme d'essai et procede associe | |
| WO2007070376A8 (fr) | Diagnostic, pronostic et suivi de la progression du lupus erythemateux systemique par analyse de microreseaux de leucocytes sanguins | |
| GB2477053B (en) | Droplet-based assay system | |
| DK1745144T3 (da) | Analysefremgangsmåde til opsporing af lægemidler på grundlag af in vitro-differentierede celler | |
| WO2005076887A3 (fr) | Procedes et systemes d'echantillonnage, de criblage et de diagnostic | |
| WO2009146450A3 (fr) | Procédés de surveillance des taux de médicaments immunosuppresseurs, de la fonction rénale, et de la fonction hépatique à l’aide d’échantillons de petit volume | |
| ES2422735T3 (es) | Procedimiento para la predicción de un riesgo de reacciones adversas a medicamentos mediante la determinación de HLA-B 1502 | |
| WO2001040517A3 (fr) | Evaluation et prediction cliniques obtenues par analyse d"expression genique | |
| WO2004096985A3 (fr) | Procedes d'evaluation de la diversite biologique | |
| WO2008112567A3 (fr) | Procédé et appareil d'évaluation quantitative de troubles neuromoteurs | |
| ATE527543T1 (de) | Testvorrichtung zur schnelldiagnose | |
| WO2007114986A3 (fr) | Sondes coopératives et leurs procédés d'utilisation | |
| WO2007001081A3 (fr) | Methode discriminante individuelle et jeu ordonne d'echantillons, appareil et systeme pour un test discriminant individuel | |
| WO2002012892A3 (fr) | Panneaux multiples rapides de biomarqueurs des ait/avc dans des analyses sanguines en laboratoire | |
| WO2019204340A3 (fr) | Biomarqueur pour prédire l'allure d'un cheval et méthodes d'utilisation associées | |
| WO2006060393A3 (fr) | Analyse systemique biologique | |
| WO2008145701A9 (fr) | Procédé de prédiction de l'évolution d'un patient malade de manière critique | |
| WO2005121362A3 (fr) | Methode de quantification selective d'isoformes de vegf dans un echantillon biologique et ses utilisations | |
| WO2004113574A3 (fr) | Methodes de depistage d'une maladie | |
| DK2274623T3 (da) | Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension | |
| WO2005056839A3 (fr) | Amorces et sondes pour detecter des genotypes du papillomavirus humain genital | |
| WO2007113685A3 (fr) | UTILISATION D'UNE CHAÎNE α DE SPECTRINE CERÉBRALE ET DE FRAGMENTS DE CELLE-CI POUR DIAGNOSTIQUER DES MALADIES CÉRÉBRALES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |